News and Analysis

Clene Nanomedicine scores $42.5m Series D

Salt Lake City, Utah-based Clene Nanomedicine Inc, a clinical-stage biopharmaceutical company, has secured $42.5 million in Series D financing.

-

Salt Lake City, Utah-based Clene Nanomedicine Inc, a clinical-stage biopharmaceutical company, has secured $42.5 million in Series D financing. SymBiosis II LLC led the round.

Source: Press Release